Mallinckrodt posts q1 loss per share of $0.60

Reports earnings for the first quarter 2020 and highlights pipeline progress.q1 adjusted earnings per share $1.64.q1 loss per share $0.60.q1 sales $665.8 million.expect next few quarters will be challenging due to impact of covid-19.continues to work to resolve outstanding issues related to opioids and acthar gel.considers all available options to address legal and financial challenges related to opioids and acthar gel.does not anticipate significant covid-19-related manufacturing or supply chain disruptions.acthar gel net sales were $167.6 million, a 25.1% decrease in quarter.expects impact due to covid-19 stay-at-home orders will be more significant in q2 at least.cash balance at the end of q1 was $808.0 million, and the revolving credit facility was fully drawn.as of tuesday's earnings announcement, the current cash balance is in excess of $700 million.as of today's earnings announcement, current cash balance is in excess of $700 million.q1 earnings per share view $1.43, revenue view $688.3 million -- refinitiv ibes data.
MNK Ratings Summary
MNK Quant Ranking